Status:
RECRUITING
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial compares the use of a shared decision-making communication tool during a clinical encounter to standard care for improving the quality of the shared decision-making process among p...
Detailed Description
PRIMARY OBJECTIVES: I. Encounters where standard of care and the non-small cell lung cancer (NSCLC) choice conversation aid were utilized will have an improvement in the quality of the shared decisio...
Eligibility Criteria
Inclusion
- CLINICIANS:
- All clinicians within identified departments participating are eligible (doctor of medicine \[MD\]/doctor of osteopathy \[DO\], fellows/residents, physician assistant \[PA\]/nurse practitioner \[NP\])
- PATIENTS:
- Adult patients (\>= 18 years of age)
- Appointments at Mayo Clinic in Rochester
- Non-small cell lung cancer (NSCLC) stage \> 1B
- Eligible by their oncologist for adjuvant treatment
Exclusion
- Exclude patient with major barriers to provide written informed consent or to participate in shared decision-making (i.e., dementia, severe hearing or visual impairment)
Key Trial Info
Start Date :
November 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06122064
Start Date
November 20 2023
End Date
October 31 2026
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905